1.5. Analysis.
Comparison 1: Emicizumab prophylaxis versus on‐demand therapy in people with inhibitors, Outcome 5: HRQoL—EQ‐5D‐5L Utility Index Score
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.